Journal article
A Phase III Randomized Trial of the Timing of Meloxicam With Iodine-125 Prostate Brachytherapy
Abstract
PURPOSE: Nonsteroidal anti-inflammatory medication is used to reduce prostate edema and urinary symptoms following prostate brachytherapy. We hypothesized that a cyclooxygenase-2 (COX-2) inhibitor regimen started 1 week prior to seed implant might diminish the inflammatory response, thus reducing edema, retention rates, and symptom severity.
METHODS AND MATERIALS: From March 2004 to February 2008, 316 men consented to an institutional review …
Authors
Crook J; Patil N; Wallace K; Borg J; Zhou D; Ma C; Pond G
Journal
International Journal of Radiation Oncology • Biology • Physics, Vol. 77, No. 2, pp. 496–501
Publisher
Elsevier
Publication Date
June 2010
DOI
10.1016/j.ijrobp.2009.04.078
ISSN
0360-3016